Lehrstuhl für Medizinische Physik und Mikrogewebetechnik

BIOMECHANICAL PROPERTIES OF RADIAL BONE ARE DIFFERENT BETWEEN AUTO-ANTIBODY POSITIVE AND NEGATIVE RHEUMATOID ARTHRITIS (2018) Stemmler F, Simon D, Liphardt AM, Englbrecht M, Rech J, Hueber A, Engelke K, et al. Conference contribution A comparative analysis of articular bone in large cohort of patients with chronic inflammatory diseases of the joints, the gut and the skin (2018) Simon D, Kleyer A, Englbrecht M, Stemmler F, Simon C, Berlin A, Kocijan R, et al. Journal article Bone: High-intensity exercise to prevent fractures - risk or gain? (2018) Kemmler W, von Stengel S Journal article Biomechanical properties of bone are impaired in patients with ACPA-positive rheumatoid arthritis and associated with the occurrence of fractures (2018) Stemmler F, Simon D, Liphardt AM, Englbrecht M, Rech J, Hueber A, Engelke K, et al. Journal article Prior-based multi material decomposition (PBMMD) for dual energy CT (2018) Dorn S, Chen S, Sawall S, Maier J, Knaup M, Maier A, Lell M, Kachelriess M Conference contribution Organ-specific context-sensitive CT image reconstruction and display (2018) Dorn S, Chen S, Sawall S, Simons D, May M, Maier J, Knaup M, et al. Conference contribution, Conference Contribution Context-sensitive organspecific evaluation and analysis of dual energy computed tomography (DECT) (2018) Dorn S, Chen S, Pisana F, Özdemir M, Maier J, Sawall S, Knaup M, et al. Conference contribution QUANTITATIVE ASSESSMENT AND ANALYSIS OF HAND MUSCLE VOLUME (2017) Friedberger A, Figueiredo C, Museyko O, Grimm A, D'Oliveira I, Bäuerle T, Rech J, et al. Conference contribution INCREASE OF CORTICAL MICRO-CHANNELS (COMICS) AS A NEW FEATURE OF STRUCTURAL DAMAGE IN PAIENTS WITH RHEUMATOID ARTHRITIS (2017) Werner D, Simon D, Englbrecht M, Stemmler F, Berlin A, Haschka J, Renner N, et al. Conference contribution Romosozumab (sclerostin monoclonal antibody) versus teriparatide in postmenopausal women with osteoporosis transitioning from oral bisphosphonate therapy: a randomised, open-label, phase 3 trial (2017) Langdahl BL, Libanati C, Crittenden DB, Bolognese MA, Brown JP, Daizadeh NS, Dokoupilova E, et al. Journal article